GEN1079
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GEN1079, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors [Phase 1]